Cash · 2011–2025
Jazz Pharmaceuticals cash
$1.4B−42.3% · FY2025
Jazz Pharmaceuticals (JAZZ) reported $1.4B in cash for fiscal 2025, −42.3% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.4B | −42.3% | Open → |
| FY20242024-12-31 | $2.4B | +60.2% | Open → |
| FY20232023-12-31 | $1.5B | +70.9% | Open → |
| FY20222022-12-31 | $881M | +49.0% | Open → |
| FY20212021-12-31 | $591M | −44.1% | Open → |
| FY20202020-12-31 | $1.1B | +66.0% | Open → |
| FY20192019-12-31 | $637M | +105.8% | Open → |
| FY20182018-12-31 | $310M | −19.8% | Open → |
| FY20172017-12-31 | $386M | +5.5% | Open → |
| FY20162016-12-31 | $366M | −63.0% | Open → |
| FY20152015-12-31 | $989M | +44.6% | Open → |
| FY20142014-12-31 | $684M | +7.5% | Open → |
| FY20132013-12-31 | $637M | +64.4% | Open → |
| FY20122012-12-31 | $387M | +371.8% | Open → |
| FY20112011-12-31 | $82.1M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +22.4%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Jazz Pharmaceuticals cash |url=https://companiesranked.com/en/company/jazz-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Jazz Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/jazz-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-jazz-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Jazz Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/jazz-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001232524-26-000045 · August 3, 2026
{{cite web |title=Jazz Pharmaceuticals cash — 10-Q (0001232524-26-000045) |url=https://www.sec.gov/Archives/edgar/data/1232524/000123252426000045/jazz-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.